DOCSLIB.ORG

Expression and Functional Role of a Transcribed Noncoding RNA with an Ultraconserved Element in Hepatocellular Carcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Expression and Functional Role of a Transcribed Noncoding RNA with an Ultraconserved Element in Hepatocellular Carcinoma Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma Chiara Braconia, Nicola Valerib, Takayuki Kogurea, Pierluigi Gasparinib, Nianyuan Huanga, Gerard J. Nuovoc, Luigi Terraccianod, Carlo M. Croceb, and Tushar Patela,1 Departments of aInternal Medicine, bMolecular Virology, Immunology, and Medical Genetics, and cPathology, College of Medicine, Ohio State University, Columbus, OH 43210; and dMolecular Pathology Division, Institute of Pathology, University Hospital Basel, 4003 Basel, Switzerland Edited by Raymond L. White, University of California at San Francisco, Emeryville, CA, and approved December 9, 2010 (received for review July 28, 2010) Although expression of non–protein-coding RNA (ncRNA) can be shown to be involved in the modulation of cell proliferation and altered in human cancers, their functional relevance is unknown. apoptosis (12–15). Recent studies revealing the presence of Ultraconserved regions are noncoding genomic segments that are several hundred long transcribed ncRNAs raise the possibility 100% conserved across humans, mice, and rats. Conservation of that many ncRNAs contributing to cancer remain to be discov- gene sequences across species may indicate an essential functional ered (16). Other than microRNAs, however, only a handful of role, and therefore we evaluated the expression of ultraconserved ncRNAs have been implicated in hepatocarcinogenesis (17–20). RNAs (ucRNA) in hepatocellular cancer (HCC). The global expres- For the most part, the function of these ncRNAs is unknown. sion of ucRNAs was analyzed with a custom microarray. Expression Sequence conservation across species has been postulated to in- was verified in cell lines by real-time PCR or in tissues by in situ dicate that a given ncRNA may have a cellular function (21, 22). A genome-wide survey identified several hundred ncRNAs with hybridization using tissue microarrays. Cellular ucRNA expression > was modulated with siRNAs, and the effects on global gene ex- a size 200 bp that showed a remarkable conservation with 100% pression and growth of human and murine HCC cells were evalu- identity across the human, mouse, and rat genomes (23). These highly conserved ncRNAs have been named ultraconserved ele- ated. Fifty-six ucRNAs were aberrantly expressed in HepG2 cells ments and are conserved across many other species as well, with compared with nonmalignant hepatocytes. Among these ucRNAs, 99% of these RNAs showing high levels of conservation within the greatest change was noted for ultraconserved element 338 the dog, 97% within the chicken, and 67% within the fugu (uc.338), which was dramatically increased in human HCC com- genomes. Their wide distribution in the genome and lack of pared with noncancerous adjacent tissues. Although uc.338 is natural variation in the human population suggested that these PCBP2 partially located within the poly(rC) binding protein 2 ( ) ultraconserved regions have a biological function that is essential gene, the transcribed ncRNA encoding uc.338 is expressed inde- for normal cells (24, 25). pendently of PCBP2 and was cloned as a 590-bp RNA gene, termed Recent genome-wide expression profiling studies showed that TUC338. Functional gene annotation analysis indicated predomi- transcribed ultraconserved RNAs (ucRNAs) exhibit distinct nant effects on genes involved in cell growth. These effects were profiles in various human cancers (26, 27). Aberrant expression experimentally demonstrated in both human and murine cells. of specific ucRNA has been linked with leukemia and several siRNA to TUC338 decreased both anchorage-dependent and an- solid tumors. The ultraconserved element 73 (uc.73), for exam- chorage-independent growth of HCC cells. These studies identify ple, modulates apoptosis and cell proliferation in colorectal a critical role for TUC338 in regulation of transformed cell growth cancer cells (26). A correlation of some ucRNA with clinical and of transcribed ultraconserved ncRNA as a unique class of prognostic factors, such as Myc amplification, has been reported genes involved in the pathobiology of HCC. in neuroblastoma (28). Although rare, single-nucleotide poly- morphisms in ultraconserved regions have been reported in liver cancer | hepatocarcinoma | exaptation | transposon familial breast cancer, chronic lymphocytic leukemia, and co- lorectal cancer (29, 30). The functional role of ucRNAs in hu- epatocellular carcinogenesis involves a complex interaction man cancer behavior and development is unknown, and our aims Hof genes resulting in variable modulation of key pathways were to evaluate their expression and potential involvement in involved in tumor cell growth. By using molecular techniques growth regulation in human HCC. fi for global genomic pro ling, the transcriptome in hepatocellular Results and Discussion cancers (HCCs) has been described, and several genes that are differentially activated have been identified. The major focus of Aberrant Expression of Selected ucRNAs in Malignant Hepatocytes. fi fi attention in these efforts has been on the characterization of ex- Genome-wide expression pro ling identi ed 56 ucRNAs, rep- pression of protein-coding genes and their use for determining resenting 11% of all ucRNAs analyzed, that were aberrantly and fi < clinical outcomes (1–9). However, the majority of the human ge- signi cantly (P 0.05) expressed in malignant HepG2 cells nome consists of non–protein-coding RNA (ncRNA). Increasing compared with nonmalignant human hepatocytes (Fig. 1A). Of evidence points to an important functional or regulatory role of these, 33 were increased by 1.3- to 6.9-fold, whereas 23 were ncRNA in cellular processes as well as a contribution of aberrant decreased by 0.8- to 0.3-fold in malignant hepatocytes. Exonic ncRNA expression to disease phenotypes. ucRNAs were not selectively enriched in malignant cells, and the Along with the highly abundant transfer and ribosomal RNAs, ncRNAs include microRNAs that modulate mRNA expression, small nucleolar RNAs that guide chemical modification of RNA Author contributions: C.B. and T.P. designed research; C.B., N.V., T.K., P.G., N.H., G.J.N., molecules, siRNAs that account for the interference pathway, and T.P. performed research; L.T. and C.M.C. contributed new reagents/analytic tools; C.B. Piwi-RNAs that are linked to transcriptional gene silencing of analyzed data; and C.B. and T.P. wrote the paper. retrotransposons, and long ncRNAs, whose role is still unknown The authors declare no conflict of interest. (10, 11). The role played by the ncRNA genome in malignant This article is a PNAS Direct Submission. transformation and tumor growth in HCC is being increasingly 1To whom correspondence should be addressed. E-mail: [email protected]. recognized. We and others have recently provided data from This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. profiling studies in which several microRNAs were identified and 1073/pnas.1011098108/-/DCSupplemental. 786–791 | PNAS | January 11, 2011 | vol. 108 | no. 2 www.pnas.org/cgi/doi/10.1073/pnas.1011098108 Downloaded by guest on October 1, 2021 exonic A B non exonic A B uc.338 possibly exonic uc.20 uc.189 100 35 * 0.00 90 * 844.cu 431.cu 30 80 0.01 100 70 HCC 25 * 29 23 60 90 Cirrhotic liver 20 0.02 80 50 Cases, % Non cirrhotic 70 40 15 liver 30 p value 60 0.03 42 54 10 50 20 0.04 40 10 5 uc.338 positivity, % of % of positivity, cells uc.338 uc.24 % Percentage, 30 0 0 20 29 negative weak moderate strong 0.05 23 non cirrhotic cirrhotic HCC 10 5-19 20-49 50 liver liver 0 0.06 s uc.338 positivity, % of cells d A e -3 -2 -1 0 1 2 3 4 fi N i R d c Fold change, o 2 u m G 1 scrambled probe log2 s p 8 C D A e 4 probe anti-uc.338 HepG2 / HH N H ll 5 R n a c i u 4 3 HCC Fig. 1. ucRNAs are aberrantly expressed in malignant hepatocytes. (A) 2 increased Genome-wide expression profiling was performed in HepG2 malignant cells 1 0 and normal human hepatocytes (HH). Fifty-six ucRNAs were aberrantly ex- score uc.338 adjacent -1 pressed in malignant hepatocytes with P < 0.05, with 12 ucRNAs increased non cancerous -2 and 7 decreased by greater than twofold. The ratio of expression of these liver -3 ucRNAs in malignant cells relative to nonmalignant cells is plotted against the -4 decreased -5 P value. Selected ucRNAs with a greater than threefold change in expression are annotated. (B) The genomic locations of the ucRNA as exonic, nonexonic, Fig. 3. uc.338 is overexpressed in human HCC tissues. uc.338 expression was or possibly exonic relative to protein-coding genes is depicted for all ucRNAs evaluated in a total of 221 HCCs, 72 cases of noncirrhotic liver tissues, and 97 and for the group of ucRNAs that are aberrantly expressed in malignant cases of cirrhotic adjacent liver tissues. Paraffin-embedded, formalin-fixed hepatocytes. Selective enrichment of a specific group of ucRNA based on liver tissues were incubated with LNA–anti-uc.338. (A) uc.338 expression was their genomic relationship to known protein-coding genes was not observed. classified as negative, weak, moderate, or strong based on the percentage of cells with detectable staining for uc.338. The proportion of cases of HCC, cirrhotic liver, or noncirrhotic liver within each class is depicted in the col- proportion of exonic regions in aberrantly expressed ucRNA umns. (B) The mean and 95% confidence intervals of uc.338 expression in (29% exonic, 42% nonexonic) was similar to those of all ultra- noncirrhotic liver, cirrhotic liver, and HCC tissues is shown. *P < 0.05. (C) conserved regions (Fig. 1B). The greatest change was noted for uc.338 expression was compared between 156 HCCs and their corresponding ultraconserved element 338 (uc.338), which was increased in adjacent liver tissues. Picture of representative cases are shown.
Load more

Recommended publications
  • The Emergence of Lncrnas in Cancer Biology
    Review The Emergence of lncRNAs in Cancer Biology John R. Prensner1,2 and Arul M. Chinnaiyan1–5 AbstAt R c The discovery of numerous noncoding RNA (ncRNA) transcripts in species from yeast to mammals has dramatically altered our understanding of cell biology, especially the biology of diseases such as cancer. In humans, the identification of abundant long ncRNA (lncRNA) >200 bp has catalyzed their characterization as critical components of cancer biology. Recently, roles for lncRNAs as drivers of tumor suppressive and oncogenic functions have appeared in prevalent cancer types, such as breast and prostate cancer. In this review, we highlight the emerging impact of ncRNAs in cancer research, with a particular focus on the mechanisms and functions of lncRNAs. Significance: lncRNAs represent the leading edge of cancer research. Their identity, function, and dysregulation in cancer are only beginning to be understood, and recent data suggest that they may serve as master drivers of carcinogenesis. Increased research on these RNAs will lead to a greater un- derstanding of cancer cell function and may lead to novel clinical applications in oncology. Cancer Discovery; 1(5):391–407. ©2011 AACR. intRoduction transcription reflects true biology or by-products of a leaky transcriptional system. Encompassed within these studies are A central question in biology has been, Which regions of the broad questions of what constitutes a human gene, what the human genome constitute its functional elements: those distinguishes a gene from a region that is simply transcribed, expressed as genes or those serving as regulatory elements? and how we interpret the biologic meaning of transcription.
    [Show full text]
  • Expression and Functional Role of a Transcribed Noncoding RNA with an Ultraconserved Element in Hepatocellular Carcinoma
    Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma Chiara Braconia, Nicola Valerib, Takayuki Kogurea, Pierluigi Gasparinib, Nianyuan Huanga, Gerard J. Nuovoc, Luigi Terraccianod, Carlo M. Croceb, and Tushar Patela,1 Departments of aInternal Medicine, bMolecular Virology, Immunology, and Medical Genetics, and cPathology, College of Medicine, Ohio State University, Columbus, OH 43210; and dMolecular Pathology Division, Institute of Pathology, University Hospital Basel, 4003 Basel, Switzerland Edited by Raymond L. White, University of California at San Francisco, Emeryville, CA, and approved December 9, 2010 (received for review July 28, 2010) Although expression of non–protein-coding RNA (ncRNA) can be shown to be involved in the modulation of cell proliferation and altered in human cancers, their functional relevance is unknown. apoptosis (12–15). Recent studies revealing the presence of Ultraconserved regions are noncoding genomic segments that are several hundred long transcribed ncRNAs raise the possibility 100% conserved across humans, mice, and rats. Conservation of that many ncRNAs contributing to cancer remain to be discov- gene sequences across species may indicate an essential functional ered (16). Other than microRNAs, however, only a handful of role, and therefore we evaluated the expression of ultraconserved ncRNAs have been implicated in hepatocarcinogenesis (17–20). RNAs (ucRNA) in hepatocellular cancer (HCC). The global expres- For the most part, the function of these ncRNAs is unknown. sion of ucRNAs was analyzed with a custom microarray. Expression Sequence conservation across species has been postulated to in- was verified in cell lines by real-time PCR or in tissues by in situ dicate that a given ncRNA may have a cellular function (21, 22).
    [Show full text]
  • DISCOVERY and CHARACTERIZATION of LONG NON-CODING Rnas in PROSTATE CANCER by John R. Prensner a Dissertation Submitted in Parti
    DISCOVERY AND CHARACTERIZATION OF LONG NON-CODING RNAs IN PROSTATE CANCER by John R. Prensner A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Molecular and Cellular Pathology) in the University of Michigan 2012 Doctoral Committee: Professor Arul M. Chinnaiyan, Chair Professor David Beer Professor Kathleen Cho Professor David Ginsburg Assistant Professor Yali Dou © John R. Prensner All Rights Reserved 2012 ACKNOWLEDGEMENTS This work represents the combined efforts of many talented individuals. First, my mentor, Arul Chinnaiyan, deserves much credit for guiding me through this experience and pushing me to produce the best science that I could. My thesis committee—Kathy Cho, David Beer, David Ginsburg, and Yali Dou—was an integral part of my development and I am truly grateful for their participation in my education. I am also indebted to the many collaborators who have contributed to this work. Foremost, Matthew Iyer has been responsible for much of my progress and has been an invaluable colleague. Saravana M. Dhanasekaran mentored me and taught me much of what I know. Wei Chen has spent countless hours working on these projects. I have also been fortunate to collaborate with Felix Feng, Qi Cao, Alejandro Balbin, Sameek Roychowdhury, Brendan Veeneman, Lalit Patel, Anirban Sahu, Chad Brenner, Irfan Asangani, and Xuhong Cao who have helped to make this thesis possible. I would like to extend my appreciation to my wonderful support network at MCTP and the MSTP office: Karen Giles, Christine Betts, Dianna Banka, Ron Koenig, Ellen Elkin, and Hilkka Ketola, who have been immensely supportive and helpful during my training.
    [Show full text]
  • Long Non-Coding Rnas Are Differentially Expressed in Hepatocellular Carcinoma Cell Lines with Different Metastatic Potential
    DOI:http://dx.doi.org/10.7314/APJCP.2014.15.23.10513 Long non-coding RNAs are Differentially Expressed in Hepatocellular Carcinoma Cell Lines with Different Metastatic Potential RESEARCH ARTICLE Long Non-coding RNAs are Differentially Expressed in Hepatocellular Carcinoma Cell Lines with Differing Metastatic Potential Ting-Ting Fang, Xiao-Jing Sun, Jie Chen, Yan Zhao, Rui-Xia Sun, Ning Ren*, Bin-Bin Liu* Abstract Background: Metastasis is a major reason for poor prognosis in patients with cancer, including hepatocellular carcinoma (HCC). A salient feature is the ability of cancer cells to colonize different organs. Long non-coding RNAs (lncRNAs) play important roles in numerous cellular processes, including metastasis. Materials and Methods: In this study, the lncRNA expression profiles of two HCC cell lines, one with high potential for metastasis to the lung (HCCLM3) and the other to lymph nodes (HCCLYM-H2) were assessed using the Arraystar Human LncRNA Array v2.0, which contains 33,045 lncRNAs and 30,215 mRNAs. Coding-non-coding gene co-expression (CNC) networks were constructed and gene set enrichment analysis (GSEA) was performed to identify lncRNAs with potential functions in organ-specific metastasis. Levels of two representative lncRNAs and one representative mRNA, RP5-1014O16.1, lincRNA-TSPAN8 and TSPAN8, were further detected in HCC cell lines with differing metastasis potential by qRT-PCR. Results: Using microarray data, we identified 1,482 lncRNAs and 1,629 mRNAs that were differentially expressed (≥1.5 fold-change) between the two HCC cell lines. The most upregulated lncRNAs in H2 were RP11-672F9.1, RP5-1014O16.1, and RP11-501G6.1, while the most downregulated ones were lincRNA-TSPAN8, lincRNA-CALCA, C14orf132, NCRNA00173, and CR613944.
    [Show full text]
  • Microrna-29 Can Regulate Expression of the Long Non-Coding RNA Gene MEG3 in Hepatocellular Cancer
    Oncogene (2011) 30, 4750–4756 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc SHORT COMMUNICATION microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer C Braconi1, T Kogure1,2, N Valeri1, N Huang1, G Nuovo3, S Costinean1, M Negrini4, E Miotto4, CM Croce1 and T Patel1,2 1College of Medicine, and the Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA; 2Mayo Clinic, Jacksonville, FL, USA; 3Department of Pathology, Ohio State University, Columbus, OH, USA and 4Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy The human genome is replete with long non-coding RNAs Introduction (lncRNA), many of which are transcribed and likely to have a functional role. Microarray analysis of 423 000 Recent large scale complementary DNA cloning lncRNAs revealed downregulation of 712 (B3%) lncRNA projects have identified that a large portion of the in malignant hepatocytes, among which maternally mammalian genome is transcribed, although only a expressed gene 3 (MEG3) was downregulated by 210-fold small fraction of these transcripts represent protein- relative to expression in non-malignant hepatocytes. coding genes (Kawaji et al., 2011). The functional role MEG3 expression was markedly reduced in four human for most of these transcripts remains obscure and their hepatocellular cancer (HCC) cell lines compared with relevance to human physiology and disease is undefined. normal hepatocytes by real-time PCR. RNA in situ Although the role of protein-coding genes as oncogenes hybridization showed intense cytoplasmic expression of or onco-suppressors has been extensively studied, the MEG3 in non-neoplastic liver with absent or very weak involvement of non-protein coding genes in tumor expression in HCC tissues.
    [Show full text]
  • ゲノムの超保存領域から転写されるlong Non-Coding RNAの肝細胞癌における発現と機能解析
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE ゲノムの超保存領域から転写されるlong non-coding RNAの肝細胞癌における発現と機能解析 著者 ?井 智 学位授与機関 Tohoku University 学位授与番号 11301甲第18525号 URL http://hdl.handle.net/10097/00126031 博士論文 ゲノムの超保存領域から転写される long non-coding RNA の 肝細胞癌における発現と機能解析 東北大学大学院医学系研究科医科学専攻 内科病態学講座 消化器病態学分野 高井 智 1 Ⅰ、略語集 DMSO：dimethyl sulfoxide ucRNA：ultraconserved RNA PCR：polymerase chain reaction TUCRNA：transcribed ultraconserved RNA siRNA：small interfering RNA AFP：α-fetoprotein PIVKA-2：protein induced by vitamin K absence or antagonist-Ⅱ cDNA：complementary DNA UICC：Unio Internationalis Contra Cancrum miR：microRNA 2 Ⅱ、要約 【背景・目的】 ヒト、マウス、ラットの三生物種で完全に保存された 200 bp 以上の超保存領域が 481 個存在する。これらから転写される long non-coding RNA (ucRNA)は種々の癌腫 で異常な発現を示すことが報告されている。肝細胞癌の発症に関与する ucRNA を同定 して機能解析を行い、バイオマーカー・治療標的としての有用性を明らかにすること を目的として研究を行った。 【方法と結果】 481 個の超保存領域のうち、タンパクコード領域とオーバーラップせず、タキフグ・ ニワトリとも完全に保存された 95 領域から転写される ucRNA を検出するカスタム PCR アレイを作成し、肝切除を行った肝癌患者の腫瘍組織における ucRNA の発現を網羅的 に解析した。計 9 例の患者における検討の結果、肝癌特異的に高発現する ucRNA とし て uc.353 の転写産物が同定され、TUC353 と名付けた。計 14 例の腫瘍組織における TUC353 の発現量を定量 PCR で検討した結果、10 例（ 71.4 ％）の症例において、TUC353 の高発現を認めた。肝癌患者の臨床背景と TUC353 の発現の関連を検討したところ、 TUC353 高発現は、腫瘍マーカーAFP-L3 分画との相関を認め、TUC353 の肝細胞癌の悪 性度との関連が示唆された。ヒト肝癌細胞株（HepG2、Hep3B、Huh-7、PLC/PRF/5）に 3 おいて TUC353 の発現を siRNA を用いて抑制した結果、すべての細胞株において足場 依存性細胞増殖が抑制された。HepG2 細胞に TUC353 siRNA を導入して発現を抑制し、 cDNA マイクロアレイを用いて網羅的遺伝子発現プロファイリングを行い、TUC353 の 関与する生物学的機能を探索した。TUC353 の抑制により、計 527 個の遺伝子が 2 倍以 上の発現変動を示し、181 個に発現上昇を、346 個に発現低下を認め、遺伝子オント ロジー解析の結果、転写活性・アポトーシス・細胞接着を含む 15 のオントロジーが 抽出された。siRNA
    [Show full text]
  • Long Noncoding RNA and Cancer: a New Paradigm Arunoday Bhan, Milad Soleimani, and Subhrangsu S
    Published OnlineFirst July 12, 2017; DOI: 10.1158/0008-5472.CAN-16-2634 Cancer Review Research Long Noncoding RNA and Cancer: A New Paradigm Arunoday Bhan, Milad Soleimani, and Subhrangsu S. Mandal Abstract In addition to mutations or aberrant expression in the moting (oncogenic) functions. Because of their genome-wide protein-coding genes, mutations and misregulation of noncod- expression patterns in a variety of tissues and their tissue- ing RNAs, in particular long noncoding RNAs (lncRNA), appear specific expression characteristics, lncRNAs hold strong prom- to play major roles in cancer. Genome-wide association studies ise as novel biomarkers and therapeutic targets for cancer. In of tumor samples have identified a large number of lncRNAs this article, we have reviewed the emerging functions and associated with various types of cancer. Alterations in lncRNA association of lncRNAs in different types of cancer and dis- expression and their mutations promote tumorigenesis and cussed their potential implications in cancer diagnosis and metastasis. LncRNAs may exhibit tumor-suppressive and -pro- therapy. Cancer Res; 77(15); 3965–81. Ó2017 AACR. Introduction lncRNAs (lincRNA) originate from the region between two pro- tein-coding genes; enhancer lncRNAs (elncRNA) originate from Cancer is a complex disease associated with a variety of genetic the promoter enhancer regions; bidirectional lncRNAs are local- mutations, epigenetic alterations, chromosomal translocations, ized within the vicinity of a coding transcript of the opposite deletions, and amplification (1). Noncoding RNAs (ncRNA) are strand; sense-overlapping lncRNAs overlap with one or more an emerging class of transcripts that are coded by the genome but introns and exons of different protein-coding genes in the sense are mostly not translated into proteins (2).
    [Show full text]
  • The Functional Role of Long Non-Coding RNA in Human Carcinomas Ewan a Gibb1*, Carolyn J Brown1,2 and Wan L Lam1,3
    Gibb et al. Molecular Cancer 2011, 10:38 http://www.molecular-cancer.com/content/10/1/38 REVIEW Open Access The functional role of long non-coding RNA in human carcinomas Ewan A Gibb1*, Carolyn J Brown1,2 and Wan L Lam1,3 Abstract Long non-coding RNAs (lncRNAs) are emerging as new players in the cancer paradigm demonstrating potential roles in both oncogenic and tumor suppressive pathways. These novel genes are frequently aberrantly expressed in a variety of human cancers, however the biological functions of the vast majority remain unknown. Recently, evidence has begun to accumulate describing the molecular mechanisms by which these RNA species function, providing insight into the functional roles they may play in tumorigenesis. In this review, we highlight the emerging functional role of lncRNAs in human cancer. Introduction non-coding genes, by post-transcriptional silencing or One of modern biology’s great surprises was the discovery infrequently by activation [33-35]. miRNAs serve as major that the human genome encodes only ~20,000 protein- regulators of gene expression and as intricate components coding genes, representing <2% of the total genome of the cellular gene expression network [33-38]. Another sequence [1,2]. However, with the advent of tiling resolu- newly described subclass are the transcription initiation tion genomic microarrays and whole genome and tran- RNAs (tiRNAs), which are the smallest functional RNAs scriptome sequencing technologies it was determined that at only 18 nt in length [39,40]. While a number of small at least 90% of the genome is actively transcribed [3,4]. ncRNAs classes, including miRNAs, have established roles The human transcriptome was found to be more complex in tumorigenesis, an intriguing association between the than a collection of protein-coding genes and their splice aberrant expression of ncRNA satellite repeats and cancer variants; showing extensive antisense, overlapping and has been recently demonstrated [41-46].
    [Show full text]